Page last updated: 2024-11-02

oxaprozin and Liver Dysfunction

oxaprozin has been researched along with Liver Dysfunction in 3 studies

Oxaprozin: An oxazole-propionic acid derivative, cyclooxygenase inhibitor, and non-steroidal anti-inflammatory drug that is used in the treatment of pain and inflammation associated with of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; and ARTHRITIS, JUVENILE.
oxaprozin : A monocarboxylic acid that is a propionic acid derivative having a 4,5-diphenyl-1,3-oxazol-2-yl substituent at position 3. It is non-steroidal anti-inflammatory drug commonly used to relieve the pain and inflammatory responses associated with osteoarthritis and rheumatoid arthritis.

Research Excerpts

ExcerptRelevanceReference
"Oxaprozin is a nonsteroidal anti-inflammatory drug which reaches peak plasma concentrations 2 to 6 hours after oral administration."2.40Clinical pharmacokinetics of oxaprozin. ( Davies, NM, 1998)
"Oxaprozin has been shown to cause mild elevation of liver enzymes in clinical studies."1.30Oxaprozin-induced symptomatic hepatotoxicity. ( Kethu, SR; Lansford, CL; Rukkannagari, S, 1999)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Manoukian, AV1
Carson, JL1
Davies, NM1
Kethu, SR1
Rukkannagari, S1
Lansford, CL1

Reviews

2 reviews available for oxaprozin and Liver Dysfunction

ArticleYear
Nonsteroidal anti-inflammatory drug-induced hepatic disorders. Incidence and prevention.
    Drug safety, 1996, Volume: 15, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Chemical and Drug Induced Liver Injur

1996
Clinical pharmacokinetics of oxaprozin.
    Clinical pharmacokinetics, 1998, Volume: 35, Issue:6

    Topics: Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Drug Interac

1998

Other Studies

1 other study available for oxaprozin and Liver Dysfunction

ArticleYear
Oxaprozin-induced symptomatic hepatotoxicity.
    The Annals of pharmacotherapy, 1999, Volume: 33, Issue:9

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Chemical and Drug Induced Liver Injury; Fema

1999